PharmCrit

Critical care evidence through a pharmacist's lens

Evidence. Insights.
Dosed weekly for the ICU clinician.

The newest ICU trials, critically appraised and set against the evidence they join, so you know when practice should change and when it shouldn't.

Free. One email a week. Unsubscribe anytime.

℞ PharmCrit Weekly
Sig:Read 1 issue q7d
Disp:3–5 trial reviews + 1 deep dive
Indication:Staying current in critical care
Refills:Unlimited
Prescriber:[YOUR NAME], PharmD, BCCCP

In every issue

Written by a pharmacist. Built for the whole ICU team.

Every summary follows the same template, so anyone on the team, physician, APP, nurse or pharmacist, can find the question, the results and the bottom line in seconds.

Trial summaries

The week's 3–5 most important critical care trials: question, design, results and critique.

From mechanism to outcome

Did the physiologic or PK/PD rationale actually translate into outcomes that matter to patients? We follow the hypothesis all the way through.

The bottom line

One or two sentences on whether it should change your protocol, order set or next recommendation.

Test yourself

Original BCCCP-style practice questions built on each week's trials, for PharmCrit+ members.

The template

One trial, one structure, every time.

Every review is written and checked against the full paper by a board-certified critical care pharmacist.

Browse the archive →

[TRIAL NAME]

[Journal] · [Year] · [Design, n =]
Sepsis / Shock
Clinical question In [population], does [intervention] compared with [comparator] improve [outcome]?
Intervention What each group actually received, and how the control arm compares with usual care.
Rationale vs. reality The proposed mechanism or PK/PD rationale, and whether the outcomes support it.
Results Primary outcome, key secondary outcomes and safety signals, with absolute differences.
Strengths & limits What makes it trustworthy, and what makes it hard to apply to your patients.
Putting it into practice Who it applies to, safety and monitoring, and what it means for protocols and order sets.
The bottom line What this means at the bedside, in two sentences.

Coming soon

Disease state reviews

Concise, current reviews of core ICU topics, updated as new trials land. Built for residents, new ICU pharmacists and anyone preparing for BCCCP.

  • Septic shock & vasopressors
  • ARDS
  • Status epilepticus
  • AKI & RRT drug dosing
  • Sedation, analgesia & delirium
  • Anticoagulation reversal
  • Antimicrobial PK in critical illness

Plans

Start free. Go deeper when you're ready.

PharmCrit Weekly

Free

  • Weekly trial summaries
  • The pharmacist angle and bottom line for each
  • Recent issues in the archive
Subscribe free

PharmCrit+

Members

$[PRICE] / month

or $[PRICE] / year

  • Everything in the free newsletter
  • Weekly deep dive on the most important trial
  • BCCCP-style practice questions every issue
  • Disease state reviews as they launch
  • Full searchable archive
Become a member

Residency program or pharmacy department? Ask about group rates.

[PHOTO]

Who writes PharmCrit

[YOUR NAME], PharmD, BCCCP

Clinical ICU pharmacist and residency preceptor. PharmCrit is the weekly reading habit I wish every resident had: the new evidence, appraised for what it means for the patients in front of us and the protocols we build.